Apr 3 2020 |
Smart Contracts: Benefits, Legal Enforceability and Best Practices |
Proskauer Rose LLP |
Apr 3 2020 |
Will Legislation Require Coverage for COVID-19 Business Interruption Losses? |
Barnes & Thornburg LLP |
Apr 3 2020 |
COVID-19: HHS Permits Business Associates to Use and Disclose PHI for Public Health and Health Oversight Purposes Without Amending BAAs |
Foley & Lardner LLP |
Apr 3 2020 |
SEC Division of Corporation Finance Issues New C&DIs about the SEC’s Conditional Relief Order and Compliance with Rule 12b-25 |
Katten |
Apr 3 2020 |
Agencies to Consider Comments on Volcker Rule Modifications |
Katten |
Apr 3 2020 |
Claiming Tax Credits under FFCRA and CARES Act |
Varnum LLP |
Apr 3 2020 |
FBI WARNING: Cyberattacks Taking Advantage of COVID-19 |
Foley & Lardner LLP |
Apr 3 2020 |
Will Legislation Require Coverage for COVID-19 Business Interruption Losses? |
Barnes & Thornburg LLP |
Apr 3 2020 |
Commercial Payors and Medicaid Telehealth Billing |
Womble Bond Dickinson (US) LLP |
Apr 3 2020 |
Whistleblower Award? See the SEC Notices of Covered Actions for March 2020 |
Kohn, Kohn & Colapinto |
Apr 3 2020 |
Expanded CISA Guidelines Broadens the Scope of “Essential Business” for Manufacturing and Construction Operations |
Bracewell LLP |
Apr 3 2020 |
EPA Announces and Clarifies Temporary Enforcement Discretion Policy |
Bergeson & Campbell, P.C. |
Apr 3 2020 |
The SEC Opts Not to Extend Reg BI and Form CRS Compliance Deadline |
Winstead |
Apr 3 2020 |
Making Estate Planning Lemonade – Part II Opportunities in a Low Interest Rate Environment |
Ward and Smith, P.A. |
Apr 3 2020 |
Removal of Navy Captain May Have Violated Military Whistleblower Law |
Kohn, Kohn & Colapinto |
Apr 3 2020 |
Restrictions On Executive Compensation For Companies Receiving Financial Assistance Under The CARES Act |
Barnes & Thornburg LLP |
Apr 3 2020 |
FDA Funding Opportunity Announcement: “Exploring the use of Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making (U01) Clinical Trials Optional” |
Faegre Drinker |
Apr 3 2020 |
BRAG Biobased Products Blog:April 3, 2020 |
Bergeson & Campbell, P.C. |
Apr 3 2020 |
Summary of the U.S. Department of Labor’s FFCRA Regulations |
Mintz |
Apr 3 2020 |
Coronavirus and Guidance on SEC Disclosures |
Sheppard, Mullin, Richter & Hampton LLP |
Apr 3 2020 |
Covered Entities May Disclose COVID-19-Related Protected Health Information—But Only Under Certain Conditions |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
Apr 3 2020 |
CFTC Provides Relief to Certain Foreign Affiliates of FCMs in Response to COVID-19 |
Katten |
Apr 3 2020 |
Covid-19 and Your International Compliance Program: Beware of Price Mark-Ups on Medical Equipment |
McDermott Will & Schulte LLP |
Apr 3 2020 |
Cares Act Provides Significant Benefits to Real Estate Industry |
McDermott Will & Schulte LLP |
Apr 3 2020 |
Title III Coronavirus FAQs: Tips for Addressing Common ADA Title III Issues During the COVID-19 Pandemic |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
Apr 3 2020 |
Legal Liability of Healthcare Providers for Care Provided During COVID-19 Pandemic |
Epstein Becker & Green, P.C. |
Apr 3 2020 |
NAD Launches Fast-Track SWIFT Challenge Process |
Keller and Heckman LLP |
Apr 3 2020 |
Foreclosure and Forbearance Under the CARES Act |
Ward and Smith, P.A. |
Apr 3 2020 |
CARES Act Provisions Affecting Employee Benefit Plans |
Vedder Price |
Apr 3 2020 |
DOL Issues FFCRA Notices, Q&A Guidance |
Wiggin and Dana LLP |
Apr 3 2020 |
More OCR Guidance on COVID-19 and HIPAA Relief – Business Associates |
Jackson Lewis P.C. |
Apr 3 2020 |
(Update): COVID-19 Is Impacting IP Filings, Litigation and License Agreements |
Wiggin and Dana LLP |
Apr 3 2020 |
Department of Labor Temporary Rule Defines and Explains Small Business Exemption to Employer Paid Leave Requirements Under Families First Coronavirus Response Act |
Stark & Stark |
Apr 3 2020 |
Top 10 Considerations for Medtech Inventors |
Schwegman, Lundberg & Woessner, P.A. |
Apr 3 2020 |
Health Crisis Puts Video Conferencing In the Spotlight – What To Know to Avoid Risk |
Varnum LLP |